AJGP
HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a Colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ranen, N. G.
Right arrow Articles by Rovner, B. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ranen, N. G.
Right arrow Articles by Rovner, B. W.
Am J Geriatr Psychiatry 7:264-266, August 1999
© 1999 American Association for Geriatric Psychiatry

Clinical and Research Reports

Cisapride in the Treatment of Visual Hallucinations Caused by Vision Loss

The Charles Bonnet Syndrome

Neal G. Ranen, M. D., Rona E. Pasternak, M. D., and Barry W. Rovner, M. D.

Received June 17, 1998; accepted September 9, 1998. From the Department of Psychiatry and Human Behavior, Jefferson Medical College, and Wills Eye Hospital, Philadelphia, PA. Address correspondence to Dr. Rovner, Geriatric Psychiatry, Wills Eye Hospital, 900 Walnut Street, 8th Floor, Philadelphia, PA 19104.

The authors describe the use of cisapride (Propulsid), a potent 5-HT3 antagonist, in the treatment of visual hallucinations in two patients with vision loss (the Charles Bonnet syndrome).

Key Words: Cisapride • Syndromes Secondary to General Medical Disorders • Hallucinations




This article has been cited by other articles:


Home page
 J PsychopharmacolHome page
U. E. Lang, D. Stogowski, D. Schulze, M. Domula, E. Schmidt, J. GaLLinat, S. M. Tugtekin, and W. FeLber
Charles Bonnet Syndrome: successful treatment of visual hallucinations due to vision loss with selective serotonin reuptake inhibitors
J Psychopharmacol, July 1, 2007; 21(5): 553 - 555.
[Abstract] [PDF]

Home page
 Arch OphthalmolHome page
G. J. Menon
Complex Visual Hallucinations in the Visually Impaired: A Structured History-Taking Approach
Arch Ophthalmol, March 1, 2005; 123(3): 349 - 355.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
M PAULIG and H MENTRUP
Charles Bonnet's syndrome: complete remission of complex visual hallucinations treated by gabapentin
J. Neurol. Neurosurg. Psychiatry, June 1, 2001; 70(6): 813 - 814.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS
Copyright © 1999 American Association for Geriatric Psychiatry